Kailera Therapeutics logo

Kailera Therapeutics

BrandWebsite

Company Overview

Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Kailera’s most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that demonstrated positive clinical trial results in obesity in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery. Kailera’s mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health. The Company is based in Waltham, MA and San Diego, CA. For more information, visit www.kailera.com.
Founded
2024
Headquarters
Employees
51-200
85.5% growth last 12mo
Marketing Team
8
6% of company

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Job Posting Salary Data

From 1 marketing roles posted in the last 12 months

Typical Salary Range
$192,000$235,000
YEAR
100%
share salary

Community Salary Data

Help build salary transparency at Kailera Therapeutics. Share your compensation anonymously.

Contribute

Reviews

Jobs